{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:03:37Z","timestamp":1780747417696,"version":"3.54.1"},"reference-count":44,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Assoc Provid AIDS Care"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antiretroviral therapy reduces HIV morbidity, mortality, viral replication, and transmission, and viral load testing is the preferred method for monitoring effectiveness. This study assessed virologic and immunologic failure and associated factors among adults living with HIV on HAART at Jimma Medical Center, southwest Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      An institution-based cross-sectional study was conducted from February to March 2019 among 272 adults on HAART. Data were collected from medical records and structured interviews. CD4+ T-cell counts and plasma viral loads were measured using standard laboratory procedures. Data were analyzed using SPSS version 24. Descriptive statistics summarized the data, and bivariate and multivariate logistic regression analyses were performed to identify associated factors. Multicollinearity was assessed before the final model. Adjusted odds ratios (AORs) with 95% confidence intervals were reported, and a\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      -value &lt;.05 was considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the participants, 60.7% were female, with a mean age of 36.6 years and a median ART duration of 96 months. Immunologic failure occurred in 8.1% and virologic failure in 10.3%. Immunologic failure was associated with tuberculosis co-infection and poor ART adherence. Virologic failure was associated with poor adherence, baseline viral load \u22651000 copies\/mL, and CD4+ count &lt;250 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adherence support remains essential for viral suppression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/23259582261453642","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:16:22Z","timestamp":1780463782000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Virologic and Immunological Failure and Associated Factors Among Adults Living With HIV on HAART at Jimma Medical Center, Southwest Ethiopia"],"prefix":"10.1177","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7940-451X","authenticated-orcid":false,"given":"Rahel Tamrat","family":"Teshome","sequence":"first","affiliation":[{"name":"Institute of Health Sciences, Jimma University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulatu","family":"Gashaw","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Jimma University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5159-7247","authenticated-orcid":false,"given":"Aster Wakjira","family":"Garedo","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Jimma University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfaye","family":"Deme","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Jimma University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1624-3114","authenticated-orcid":false,"given":"Wondimagegn","family":"Adissu","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Jimma University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Yilma","sequence":"additional","affiliation":[{"name":"Institute of Health, Jimma University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeleke","family":"Mekonnen","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Jimma University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6660-4435","authenticated-orcid":false,"given":"Lealem Gedefaw","family":"Bimerew","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Jimma University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"e_1_3_4_2_2","volume-title":"Global HIV & AIDS statistics fact sheet 2023","author":"UNAIDS","year":"2023","unstructured":"UNAIDS. Global HIV & AIDS statistics fact sheet 2023. UNAIDS; 2023."},{"key":"e_1_3_4_3_2","volume-title":"HIV estimates report 2022","author":"Ethiopian Public Health Institute (EPHI)","year":"2022","unstructured":"Ethiopian Public Health Institute (EPHI). HIV estimates report 2022. EPHI; 2022."},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19268-1"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5884845"},{"key":"e_1_3_4_6_2","unstructured":"Eggleton JS Nagalli S. Highly active antiretroviral therapy (HAART). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing 2023."},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7212e1"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-025-00788-8"},{"key":"e_1_3_4_9_2","unstructured":"UNAIDS up date :Impact of the pause of U.S. of foreign assistance in Ethiopia Feb 2025."},{"key":"e_1_3_4_10_2","first-page":"193","article-title":"Trends of HIV infection and progress towards the 95-95-95 targets in Gambella Regional State from 2019 to 2023, southwest Ethiopia","volume":"16","author":"Mitiku AA","year":"2024","unstructured":"Mitiku AA, Dimore AL, Gach W. Trends of HIV infection and progress towards the 95-95-95 targets in Gambella Regional State from 2019 to 2023, southwest Ethiopia. HIV AIDS (Auckl). 2024;16:193\u2013201.","journal-title":"HIV AIDS (Auckl)"},{"key":"e_1_3_4_11_2","volume-title":"HIV drug resistance report 2017","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. HIV drug resistance report 2017. WHO; 2017."},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2320"},{"key":"e_1_3_4_13_2","volume-title":"Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health Approach","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health Approach. WHO; 2023."},{"key":"e_1_3_4_14_2","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach- 2nd ed","author":"WHO","year":"2016","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach- 2nd ed. WHO; 2016."},{"key":"e_1_3_4_15_2","volume-title":"National consolidated guidelines for comprehensive HIV prevention, care and treatment","author":"Federal Ministry of Health","year":"2018","unstructured":"Federal Ministry of Health. National consolidated guidelines for comprehensive HIV prevention, care and treatment. Ministry of Health; 2018."},{"key":"e_1_3_4_16_2","article-title":"Adherence to antiretroviral treatment and associated factors among seropositive people received treatment in Jimma town public health facilities, Ethiopia","volume":"21","author":"Demas Z","unstructured":"Demas Z, Gebremariam A, Kebede A, Ayele L. Adherence to antiretroviral treatment and associated factors among seropositive people received treatment in Jimma town public health facilities, Ethiopia. J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221121096.","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-23193-2"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-181"},{"key":"e_1_3_4_19_2","unstructured":"BD Biosciences. BD FACSPresto\u2122 near-Patient CD4 Counter :Instructions for Use. Becton Dickinson; 2014."},{"key":"e_1_3_4_20_2","unstructured":"Ethiopian Public Health Institute (EPHI). Guidelines for the Implementation of Point-of-Care CD4 Testing Technologies in Ethiopia. FMOH\/EPHI 2013."},{"key":"e_1_3_4_21_2","unstructured":"Roche Diagnostics. COBAS \u00ae AmpliPrep\/COBAS \u00ae TaqMan \u00ae HIV-1 test : package insert. 2007;1\u201336."},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196259"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125826"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10169"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijso.2020.08.001"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-018-0278-4"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.2147\/HIV.S354716"},{"issue":"1","key":"e_1_3_4_29_2","first-page":"017","article-title":"Prevalence and predictors of immunological treatment failure among HIV infect-ed adults on the first-line antiretroviral therapy in Mbeya Region, Tanzania","volume":"3","author":"Chomboko CL","year":"2018","unstructured":"Chomboko CL, Kabyemera RM, Kidenya BR, Kamugisha E. Prevalence and predictors of immunological treatment failure among HIV infect-ed adults on the first-line antiretroviral therapy in Mbeya Region, Tanzania. M J HIV. 2018;3(1):017.","journal-title":"M J HIV"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6817325"},{"issue":"55","key":"e_1_3_4_31_2","article-title":"Treatment failure and associated factors among people living with HIV on highly active antiretroviral therapy in mainland China: A systematic review and meta-analysis","volume":"18","author":"Niu D","year":"2023","unstructured":"Niu D, Tang H, Chen F, et al. Treatment failure and associated factors among people living with HIV on highly active antiretroviral therapy in mainland China: A systematic review and meta-analysis. PLoS One. 2023;18(55):e0284405.","journal-title":"PLoS One"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116255"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S280966"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.2147\/HIV.S266460"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211344"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.13603"},{"issue":"03","key":"e_1_3_4_37_2","first-page":"226","article-title":"Prevalence and factors associated with virologic failure among people living with HIV monitored in a decentralized health care facility","volume":"09","author":"Ba S","year":"2019","unstructured":"Ba S, Ba ND, Sembene L, et al. Prevalence and factors associated with virologic failure among people living with HIV monitored in a decentralized health care facility. Adv Infect Dis. 2019;09(03):226\u2013237.","journal-title":"Adv Infect Dis"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-11-9"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2018.29.191.11940","article-title":"Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011","volume":"29","author":"Kazooba P","year":"2018","unstructured":"Kazooba P, Mayanja BN, Levin J, Masiira B, Kaleebu P. Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011. Pan Afr Med J. 2018;29:191.","journal-title":"Pan Afr Med J."},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30172-7"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-021-00336-0"},{"issue":"1","key":"e_1_3_4_42_2","first-page":"1","article-title":"Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: A population-based study","volume":"20","author":"Yuan D","year":"2020","unstructured":"Yuan D, Liu M, Jia P, et al. Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: A population-based study. BMC Infect Dis. 2020;20(1):1\u201310.","journal-title":"BMC Infect Dis"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-020-00700-8"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-087569"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-036223"}],"container-title":["Journal of the International Association of Providers of AIDS Care (JIAPAC)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23259582261453642","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23259582261453642","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23259582261453642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T11:46:56Z","timestamp":1780746416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/23259582261453642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":44,"alternative-id":["10.1177\/23259582261453642"],"URL":"https:\/\/doi.org\/10.1177\/23259582261453642","relation":{},"ISSN":["2325-9582","2325-9582"],"issn-type":[{"value":"2325-9582","type":"print"},{"value":"2325-9582","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"23259582261453642"}}